At 21, the Ensenada-born rider claimed landmark victories in Europe and emerged as one of the sport’s fastest-rising talents.

The end of the earnings season is always a good time to take a step back and see who shined (and who not so much). Let’s take ...

If you are wondering whether Travere Therapeutics is still good value after its big rebound, you are not alone. This stock has quickly moved from recovery story to serious contender on many watchlists ...

"2026 will be his first full season in the Australian Formula Ford championship. It's an eight-round series travelling all ...